CBDDCBD of Denver Inc.
Price Chart
Loading chart...
About CBD of Denver Inc. (CBDD)
CBD of Denver Inc. (CBDD) is a Drug Manufacturers - Specialty & Generic company headquartered in Dietlikon, Switzerland whose shares trade over-the-counter on the Pink tier.
CBD of Denver, Inc. (OTC: CBDD) offers a full line of hemp oil an CBD products and is a producer and distributor of innovative products throughout Europe. CBD of Denver, Inc. is focused on acquiring profitable assets at attractive valuations to create value for shareholders. The company's team is dedicated to sourcing high-margin, innovative products that align with its values. For more information visit www.cbdofdenver.com.
Products and services
CBDD offers a full line of hemp oil an CBD products and is a producer and distributor of innovative products throughout Europe.
CBDD key facts
- Ticker symbol
- CBDD
- Market tier
- Pink
- Sector
- Healthcare
- Headquarters
- Dietlikon, Switzerland
- Country of incorporation
- US
- Year of incorporation
- 1993
- Employees
- 2
- Estimated market cap
- $892.6K (as of Apr 9, 2025)
- Shares outstanding
- 8,925,546,030
- Reporting standard
- Alternative Reporting Standard
- Audit status
- Unaudited
- Fiscal year end
- 12/31
- Latest filing
- Annual Report (Dec 31, 2024)
CBD of Denver Inc. leadership
- Jan Schwager — CEO
- Jonathan D. Leinwand — Corporate Counsel
Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with C
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for CBD of Denver Inc. (CBDD) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Drug Manufacturers - Specialty & Generic Companies on OTC Markets
Other OTC-traded companies in Drug Manufacturers - Specialty & Generic:
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Chief Executive Officer
Company Officers
Social Media
Business Details
Stock Details
Loading modules...